Stay updated on Prostate Cancer Marker Enrichment & Treatment Clinical Trial
Sign up to get notified when there's something new on the Prostate Cancer Marker Enrichment & Treatment Clinical Trial page.

Latest updates to the Prostate Cancer Marker Enrichment & Treatment Clinical Trial page
- Check8 days agoChange DetectedThe related topics section was reduced by removing the Prostate cancer and MedlinePlus Genetics links. This change removes ancillary health-resource links and does not affect the study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page shows minor updates to revision notes (Revision: v3.3.4) and removal of some topics (Prostate cancer, MedlinePlus Genetics). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check37 days agoChange DetectedAdded related topic links for Prostate cancer and MedlinePlus Genetics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedLocations section now consolidates study sites with province-level entries (Alberta, British Columbia, Nova Scotia, Ontario, Quebec, Saskatchewan) and the page revision shows v3.3.3. This updates the page structure to present site information more accessibly by replacing scattered per-location headings with a single Locations section.SummaryDifference0.6%

- Check73 days agoChange DetectedThe Publications note now clarifies that entries are automatically pulled from PubMed and may not all pertain to the study. The revision tag has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check80 days agoChange DetectedNotice about government funding and NIH operations was removed from the page. The study details, locations, and eligibility criteria remain unchanged.SummaryDifference0.3%

Stay in the know with updates to Prostate Cancer Marker Enrichment & Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prostate Cancer Marker Enrichment & Treatment Clinical Trial page.